Contents:
Document Title
Tranexamic acid for bleeding in palliative care
Document Date
June 2024
Document Purpose and Intended Audience
To support any healthcare professional working with palliative patients with bleeding.
Author
Sara Smith, Palliative care Advanced Clinical Practitioner.
Esther Waterhouse, Palliative care consultant.
Consultation Process
Reviewed by SPAGG and ratified
Monitoring
This will be audited and reviewed every 3 years
Review Date
(must be within three years)
July 2027
Approval Signatures:
SPAGG chair
Dr Jon Tomas
SPAGG secretary
Dr Alice Gray
Date Approved by SPAGG: July 2024
Date submitted to Area Prescribing Committee: N/A
Disclaimer
These Guidelines are intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.
Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.
Whilst SPAGG takes every care to compile accurate information , we cannot guarantee its correctness and completeness, and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.